Bleomycin-induced pneumonitis in a young Ghanaian male with Hodgkin's Lymphoma

We report a case of a young Ghanaian male who developed Bleomycin Induced Pneumonitis (BIP) after being treated for Hodgkin's Lymphoma. Pulmonary toxicity is the most feared complication of bleomycin therapy despite its effectiveness in achieving cure in patients with Hodgkin's lymphoma an...

Descripción completa

Detalles Bibliográficos
Autores principales: Dei-Adomakoh, Yvonne A, Afriyie-Mensah, Jane S, Gbadamosi, Hafisatu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ghana Medical Association 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8042802/
https://www.ncbi.nlm.nih.gov/pubmed/33883778
http://dx.doi.org/10.4314/gmj.v54i4.12
Descripción
Sumario:We report a case of a young Ghanaian male who developed Bleomycin Induced Pneumonitis (BIP) after being treated for Hodgkin's Lymphoma. Pulmonary toxicity is the most feared complication of bleomycin therapy despite its effectiveness in achieving cure in patients with Hodgkin's lymphoma and germ cell tumors. BIP has a significant mortality rate if detected late and a high index of suspicion is required in all patients on bleomycin-based therapies with sudden onset of respiratory symptoms.

Ejemplares similares